AKBA Stock Price History and Quote Analysis: Insights for Investors
Akebia Therapeutics, Inc.
Stock Price Today
Akebia Therapeutics, Inc. (AKBA) stock surged +0.76%, trading at $1.33 on NASDAQ, up from the previous close of $1.32. The stock opened at $1.35, fluctuating between $1.31 and $1.35 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 167 |
| Beta | 0.771 |
| Sales or Revenue | $194.62M |
| 5Y Sales Change% | -0.416% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Akebia Therapeutics, Inc. (NASDAQ: AKBA) stock price is $1.33 in the last trading session. During the trading session, AKBA stock reached the peak price of $1.35 while $1.31 was the lowest point it dropped to. The percentage change in AKBA stock occurred in the recent session was 0.76% while the dollar amount for the price change in AKBA stock was $0.01.
The NASDAQ listed AKBA is part of Biotechnology industry that operates in the broader Healthcare sector. Akebia Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Meredith Bowman
Senior Vice President of People
Ms. Carolyn Rucci
Senior Vice President of Legal & Gen. Counsel
Mercedes Carrasco
Director of Corporation Communications
Ms. Violetta Cotreau
Senior Vice President, Chief Accounting Officer & Principal Accounting Officer
Dr. Thierry Bilbault Ph.D.
Senior Vice President of Manufacturing & Pharmaceutical Devel.
Ms. Kimberly Garko
Senior Vice President of Quality
Mr. David A. Spellman
Principal Accounting Officer, Senior Vice President, Chief Financial Officer & Treasurer
Ms. Nicole R. Hadas
Senior Vice President, Chief Legal Officer & Sec.
Mr. John P. Butler MBA
Chief Executive Officer, Pres & Director
Ms. Nicole R. Hadas J.D.
Senior Vice President, Chief Legal Officer & Sec.
Dr. Steven Keith Burke
Senior Vice President of R&D and Chief Medical Officer
Ms. Ellen E. Snow CPA, CGMA
Senior Vice President, Chief Financial Officer, Treasurer & Principal Accounting Officer
Tracey Vetterick
Vice President of Portfolio Strategy & Corporation Admin.
Mr. Michel Dahan
Senior Vice President & Chief Operating Officer
AKBA's closing price is 70.51% higher than its 52-week low of $0.78 where as its distance from 52-week high of $2.48 is -46.37%.
Number of AKBA employees currently stands at 167.
Official Website of AKBA is: https://www.akebia.com
AKBA could be contacted at phone 617 871 2098 and can also be accessed through its website. AKBA operates from 245 First Street, Cambridge, MA 02142, United States.
AKBA stock volume for the day was 801.32K shares. The average number of AKBA shares traded daily for last 3 months was 1.93M.
The market value of AKBA currently stands at $279.68M with its latest stock price at $1.33 and 210.29M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com